Key facts
- This page summarizes Stefan Andreas Abele's Form 4 filing for Pharvaris N.V. (PHVS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 May 2026, 18:44.
Stefan Andreas Abele - 15 May 2026 Form 4 Insider Report for Pharvaris N.V. (PHVS)
- Reporting relationship
- Chief Technical Ops Officer
- Issuer ticker
- PHVS
- Reported as of
- 15 May 2026
- Net transaction value
- -$260,864
- SEC form
- 4
- Accepted by SEC
- 19 May 2026, 18:44:54 UTC
- Prior SEC filing
- 03 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marnus Nel, Attorney-in-Fact for Stefan Abele
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stefan Andreas Abele filed Form 4 for Pharvaris N.V. (PHVS) on 19 May 2026.
Change
- Previous filing in this sequence was filed on 03 Apr 2026.
- Current net transaction value: -$260,864.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002002390
Primary reporting owner
Abele Stefan Andreas
- Relationship
- Chief Technical Ops Officer
- Address
- 1 CRANBERRY HILL SUITE 400, LEXINGTON
- Signature
- /s/ Marnus Nel, Attorney-in-Fact for Stefan Abele
- Signature date
- 19 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PHVS
transaction
Common Stock
Sale
- Transaction value
- $260,864
- Shares
- -8,748
- Change %
- -20%
- Price
- $29.82
- Shares after
- 35,194
- Date
- 15 May 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates.